A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung cancer with idiopathic interstitial pneumonias: rationale and design for the TORG1936/AMBITIOUS study.

Satoshi IkedaTerufumi KatoHirotsugu KenmotsuTakashi OguraShunichiro IwasawaTae IwasawaRika KasajimaYohei MiyagiToshihiro MisumiTakeharu YamanakaHiroaki Okamoto

Published in: Therapeutic advances in medical oncology (2020)

Japan Registry of Clinical Trials, jRCTs031190084, registered 26 August 2019 - retrospectively registered, https://jrct.niph.go.jp/en-latest-detail/jRCTs031190084.

Keyphrases

phase ii study
clinical trial
open label
locally advanced
study protocol
rectal cancer
phase iii